应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GRFS 基立福
交易中 05-12 12:23:00 EDT
7.56
-0.24
-3.14%
最高
7.72
最低
7.56
成交量
47.42万
今开
7.72
昨收
7.80
日振幅
2.12%
总市值
51.98亿
流通市值
32.03亿
总股本
6.88亿
成交额
361.28万
换手率
0.11%
流通股本
4.24亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
基立福盘中异动 股价大跌5.19%报8.77美元
市场透视 · 02-27
基立福盘中异动 股价大跌5.19%报8.77美元
财报前瞻|基立福本季度营收预计增7.76%,机构观点偏审慎
财报Agent · 02-19
财报前瞻|基立福本季度营收预计增7.76%,机构观点偏审慎
美国红十字会警告血液严重短缺
环球市场播报 · 01-23
美国红十字会警告血液严重短缺
关于Grifols价格目标标题的更正
投资观察 · 2025-12-09
关于Grifols价格目标标题的更正
基立福盘中异动 股价大跌5.16%
市场透视 · 2025-03-11
基立福盘中异动 股价大跌5.16%
基立福盘中异动 早盘急速拉升5.02%报8.69美元
市场透视 · 2025-03-05
基立福盘中异动 早盘急速拉升5.02%报8.69美元
基立福在西班牙马德里交易所涨幅扩大至12%。
金融界 · 2025-02-27
基立福在西班牙马德里交易所涨幅扩大至12%。
基立福盘中异动 股价大涨5.16%
市场透视 · 2025-02-27
基立福盘中异动 股价大涨5.16%
基立福盘中异动 临近午盘股价大涨5.42%
市场透视 · 2025-02-27
基立福盘中异动 临近午盘股价大涨5.42%
基立福盘中异动 下午盘股价大跌5.11%
市场透视 · 2025-02-26
基立福盘中异动 下午盘股价大跌5.11%
基立福盘中异动 早盘股价大涨5.06%
市场透视 · 2025-02-13
基立福盘中异动 早盘股价大涨5.06%
基立福盘中异动 早盘大幅下跌5.27%报7.01美元
市场透视 · 2025-01-23
基立福盘中异动 早盘大幅下跌5.27%报7.01美元
上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元
财中社 · 2025-01-22
上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元
基立福盘中异动 大幅上涨5.10%报7.42美元
市场透视 · 2025-01-16
基立福盘中异动 大幅上涨5.10%报7.42美元
基立福盘中异动 股价大跌5.00%报7.22美元
市场透视 · 2025-01-10
基立福盘中异动 股价大跌5.00%报7.22美元
基立福盘中异动 早盘股价大跌5.10%报7.45美元
市场透视 · 2024-12-27
基立福盘中异动 早盘股价大跌5.10%报7.45美元
基立福盘中异动 下午盘股价大涨5.05%报7.81美元
市场透视 · 2024-12-20
基立福盘中异动 下午盘股价大涨5.05%报7.81美元
基立福盘中异动 股价大跌5.08%
市场透视 · 2024-12-19
基立福盘中异动 股价大跌5.08%
基立福盘中异动 大幅上涨5.18%
市场透视 · 2024-12-18
基立福盘中异动 大幅上涨5.18%
基立福盘中异动 股价大涨5.00%
市场透视 · 2024-12-12
基立福盘中异动 股价大涨5.00%
加载更多
公司概况
公司名称:
基立福
所属市场:
NASDAQ
上市日期:
--
主营业务:
GRIFOLS, S.A.于1940年在西班牙巴塞罗那成立,并于1987年6月22日注册为有限责任公司。该公司是一家全球性的血浆衍生疗法生产商,制造和分销用于治疗慢性和急性危及生命疾病的生物药物。它还运营专注于体外检测产品和医院用品的诊断业务。Grifols 是全球血浆衍生物行业销售额排名前三的生产商之一。
发行价格:
--
{"stockData":{"symbol":"GRFS","market":"US","secType":"STK","nameCN":"基立福","latestPrice":7.555,"timestamp":1778602971595,"preClose":7.8,"halted":0,"volume":474166,"delay":0,"changeRate":-0.031410256410256424,"floatShares":424000000,"shares":688000000,"eps":0.703076,"marketStatus":"交易中","change":-0.245,"latestTime":"05-12 12:23:00 EDT","open":7.72,"high":7.72,"low":7.555,"amount":3612784.9331728,"amplitude":0.021154,"askPrice":7.56,"askSize":214,"bidPrice":7.55,"bidSize":210,"shortable":3,"etf":0,"ttmEps":0.703076,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1778616000000},"marketStatusCode":2,"adr":1,"adrRate":1,"listingDate":1320120000000,"exchange":"NASDAQ","adjPreClose":7.8,"dividendRate":0.023347,"preHourTrading":{"tag":"盘前","latestPrice":7.68,"preClose":7.8,"latestTime":"09:29 EDT","volume":20721,"amount":160028.055069,"timestamp":1778592599999,"change":-0.12,"changeRate":-0.015385,"amplitude":0.019231},"postHourTrading":{"tag":"盘后","latestPrice":7.8,"preClose":7.8,"latestTime":"16:04 EDT","volume":25275,"amount":197145,"timestamp":1778529877275,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.630266,"impliedVol":0.4471,"impliedVolPercentile":0.8167},"requestUrl":"/m/hq/s/GRFS/","defaultTab":"news","newsList":[{"id":"2614565008","title":"基立福盘中异动 股价大跌5.19%报8.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614565008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614565008?lang=zh_cn&edition=full","pubTime":"2026-02-27 00:45","pubTimestamp":1772124340,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日00时45分,基立福股票出现异动,股价急速下跌5.19%。截至发稿,该股报8.77美元/股,成交量54.5809万股,换手率0.08%,振幅4.11%。最近的财报数据显示,该股实现营业收入21.80亿美元,净利润1.48亿美元,每股收益0.22美元,毛利8.57亿美元,市盈率13.87倍。基立福股票所在的制药行业中,整体跌幅为1.37%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022700454097a73151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022700454097a73151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137165143","title":"财报前瞻|基立福本季度营收预计增7.76%,机构观点偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1137165143","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137165143?lang=zh_cn&edition=full","pubTime":"2026-02-19 12:02","pubTimestamp":1771473749,"startTime":"0","endTime":"0","summary":"基立福将在2026年02月26日发布最新季度财报,市场关注收入与盈利质量的同步改善,以及血制品主业的放量表现。市场一致预期显示,本季度基立福总营收预计为20.06亿美元,同比增长7.76%;调整后每股收益预计为0.25美元,同比增长16.25%;息税前利润预计为3.63亿美元,同比下降3.27%;由于未获得本季度毛利率与净利率的明确预测数值,暂不展示相关预测信息。近期机构观点整体偏审慎,主要围绕费用端压力与盈利质量的权衡展开。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻|基立福本季度营收预计增7.76%,机构观点偏审慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605413637","title":"美国红十字会警告血液严重短缺","url":"https://stock-news.laohu8.com/highlight/detail?id=2605413637","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605413637?lang=zh_cn&edition=full","pubTime":"2026-01-23 00:00","pubTimestamp":1769097600,"startTime":"0","endTime":"0","summary":"美国红十字会报告称,在风暴和流感期间血液供应减少了约35%,敦促捐赠以支持医院;血液产品制造商基立福(GRFS)在更广泛的血液生态系统中与非营利组织一同运作。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张俊 SF065","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-23/doc-inhifeqq2507765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","SINA","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129245643","title":"关于Grifols价格目标标题的更正","url":"https://stock-news.laohu8.com/highlight/detail?id=1129245643","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129245643?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:26","pubTimestamp":1765283169,"startTime":"0","endTime":"0","summary":"“JP Morgan将Grifols的价格目标维持在每股10.00美元”于2025年12月8日11:17发布,原文错误表述价格目标从每股10.30美元下调至每股10.00美元。实际情况是价格目标维持在每股10.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRFS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518208390","title":"基立福盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208390?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:55","pubTimestamp":1741625733,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时55分,基立福股票出现异动,股价急速跳水5.16%。截至发稿,该股报8.00美元/股,成交量99.304万股,换手率0.15%,振幅2.95%。基立福股票所在的制药行业中,整体跌幅为1.82%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100553498a2c674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100553498a2c674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948832","title":"基立福盘中异动 早盘急速拉升5.02%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948832?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185081,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分,基立福股票出现异动,股价急速上涨5.02%。截至发稿,该股报8.69美元/股,成交量4.9073万股,换手率0.01%,振幅0.12%。基立福股票所在的制药行业中,整体跌幅为0.20%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223122abe9b081&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223122abe9b081&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514936389","title":"基立福在西班牙马德里交易所涨幅扩大至12%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514936389","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514936389?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:11","pubTimestamp":1740669067,"startTime":"0","endTime":"0","summary":"基立福在西班牙马德里交易所涨幅扩大至12%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27231148438873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514386458","title":"基立福盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386458?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:03","pubTimestamp":1740668598,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时03分,基立福股票出现异动,股价大幅拉升5.16%。截至发稿,该股报8.35美元/股,成交量88.3213万股,换手率0.13%,振幅4.91%。基立福股票所在的制药行业中,整体涨幅为0.79%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272303189632b81e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272303189632b81e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514286863","title":"基立福盘中异动 临近午盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514286863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514286863?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:54","pubTimestamp":1740588887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时54分,基立福股票出现异动,股价大幅上涨5.42%。截至发稿,该股报7.78美元/股,成交量76.5194万股,换手率0.11%,振幅6.91%。基立福股票所在的制药行业中,整体涨幅为0.31%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270054479893c5e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270054479893c5e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514043656","title":"基立福盘中异动 下午盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514043656?lang=zh_cn&edition=full","pubTime":"2025-02-26 03:23","pubTimestamp":1740511434,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日03时23分,基立福股票出现异动,股价大幅跳水5.11%。截至发稿,该股报7.05美元/股,成交量105.823万股,换手率0.16%,振幅8.34%。基立福股票所在的制药行业中,整体涨幅为1.36%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032354abdcc195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032354abdcc195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511863524","title":"基立福盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511863524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511863524?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:09","pubTimestamp":1739459395,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时09分,基立福股票出现异动,股价急速上涨5.06%。截至发稿,该股报7.37美元/股,成交量19.5011万股,换手率0.03%,振幅2.50%。基立福股票所在的制药行业中,整体涨幅为0.51%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230956abcdb976&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230956abcdb976&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505112720","title":"基立福盘中异动 早盘大幅下跌5.27%报7.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505112720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505112720?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642696,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分,基立福股票出现异动,股价大幅下跌5.27%。截至发稿,该股报7.01美元/股,成交量8.968万股,换手率0.01%,振幅0.27%。基立福股票所在的制药行业中,整体跌幅为0.27%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223136a22d0952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223136a22d0952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505725593","title":"上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505725593","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505725593?lang=zh_cn&edition=full","pubTime":"2025-01-22 19:53","pubTimestamp":1737546826,"startTime":"0","endTime":"0","summary":"与2024年度的实际发生情况相比,基立福全球的交易实际发生金额为4.87亿美元,较预计金额的5.62亿美元有65.73%的差异,主要因市场变化和供货商的实际放行情况影响了采购量。GDS的交易实际发生金额为0.13亿美元,低于预计的0.2亿美元,差异为1.72%。对于海尔生物的交易,2024年实际发生金额为1612万元人民币,远低于预计的金额。文章来源:财中社上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122220550a22bab64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122220550a22bab64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503622235","title":"基立福盘中异动 大幅上涨5.10%报7.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503622235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503622235?lang=zh_cn&edition=full","pubTime":"2025-01-16 01:06","pubTimestamp":1736960792,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日01时06分,基立福股票出现异动,股价快速拉升5.10%。截至发稿,该股报7.42美元/股,成交量52.3064万股,换手率0.08%,振幅3.40%。基立福股票所在的制药行业中,整体涨幅为0.57%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011601063298675f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011601063298675f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502860408","title":"基立福盘中异动 股价大跌5.00%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502860408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502860408?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:08","pubTimestamp":1736521709,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时08分,基立福股票出现异动,股价快速跳水5.00%。截至发稿,该股报7.22美元/股,成交量14.6785万股,换手率0.02%,振幅1.58%。基立福股票所在的制药行业中,整体涨幅为0.24%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230829a21d1735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230829a21d1735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494839382","title":"基立福盘中异动 早盘股价大跌5.10%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494839382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494839382?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:22","pubTimestamp":1735312922,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时22分,基立福股票出现波动,股价快速跳水5.10%。截至发稿,该股报7.45美元/股,成交量25.493万股,换手率0.04%,振幅2.17%。基立福股票所在的制药行业中,整体跌幅为0.38%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272322039851df63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272322039851df63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492110089","title":"基立福盘中异动 下午盘股价大涨5.05%报7.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492110089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492110089?lang=zh_cn&edition=full","pubTime":"2024-12-20 02:38","pubTimestamp":1734633494,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日02时38分,基立福股票出现异动,股价快速拉升5.05%。截至发稿,该股报7.81美元/股,成交量54.4987万股,换手率0.08%,振幅4.84%。基立福股票所在的制药行业中,整体跌幅为0.76%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220023814a1fbb85a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220023814a1fbb85a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492515320","title":"基立福盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492515320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492515320?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:32","pubTimestamp":1734550326,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时32分,基立福股票出现异动,股价急速跳水5.08%。截至发稿,该股报7.64美元/股,成交量46.8777万股,换手率0.07%,振幅4.22%。基立福股票所在的制药行业中,整体跌幅为0.79%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219033207a1f93ea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219033207a1f93ea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492051993","title":"基立福盘中异动 大幅上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492051993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492051993?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:19","pubTimestamp":1734455970,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时19分,基立福股票出现异动,股价大幅上涨5.18%。截至发稿,该股报8.02美元/股,成交量49.4408万股,换手率0.07%,振幅4.59%。基立福股票所在的制药行业中,整体涨幅为0.73%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801193095ea34da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801193095ea34da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490891149","title":"基立福盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490891149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490891149?lang=zh_cn&edition=full","pubTime":"2024-12-12 02:51","pubTimestamp":1733943082,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日02时51分,基立福股票出现波动,股价急速上涨5.00%。截至发稿,该股报7.56美元/股,成交量56.5658万股,换手率0.08%,振幅5.76%。基立福股票所在的制药行业中,整体跌幅为0.35%。通过 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,继该公司于 2022 年 4 月收购 Biotest 后,生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部,包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121202512295e9022e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121202512295e9022e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.grifols.com","stockEarnings":[{"period":"1week","weight":-0.0522},{"period":"1month","weight":-0.0499},{"period":"3month","weight":-0.154},{"period":"6month","weight":-0.1024},{"period":"1year","weight":0.0986},{"period":"ytd","weight":-0.1658}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.0881},{"period":"3month","weight":0.0682},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.31},{"period":"ytd","weight":0.0841}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GRIFOLS, S.A.于1940年在西班牙巴塞罗那成立,并于1987年6月22日注册为有限责任公司。该公司是一家全球性的血浆衍生疗法生产商,制造和分销用于治疗慢性和急性危及生命疾病的生物药物。它还运营专注于体外检测产品和医院用品的诊断业务。Grifols 是全球血浆衍生物行业销售额排名前三的生产商之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.000151},{"month":2,"riseRate":0.533333,"avgChangeRate":0.015168},{"month":3,"riseRate":0.4,"avgChangeRate":-0.027634},{"month":4,"riseRate":0.533333,"avgChangeRate":0.017768},{"month":5,"riseRate":0.466667,"avgChangeRate":0.020175},{"month":6,"riseRate":0.5,"avgChangeRate":0.024611},{"month":7,"riseRate":0.666667,"avgChangeRate":0.032247},{"month":8,"riseRate":0.2,"avgChangeRate":-0.039946},{"month":9,"riseRate":0.4,"avgChangeRate":-0.019738},{"month":10,"riseRate":0.466667,"avgChangeRate":-0.001201},{"month":11,"riseRate":0.466667,"avgChangeRate":0.015669},{"month":12,"riseRate":0.733333,"avgChangeRate":0.033089}],"exchange":"NASDAQ","name":"基立福","nameEN":"Grifols SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基立福,GRFS,基立福股票,基立福股票老虎,基立福股票老虎国际,基立福行情,基立福股票行情,基立福股价,基立福股市,基立福股票价格,基立福股票交易,基立福股票购买,基立福股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}